Home » Topics » Regulatory

Regulatory
RSS

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Dexmedetomidine receives FDA marketing approval

Dec. 22, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

Schwarz sells intranasal scopolamine rights to Nastech

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Novartis files NDA for extended-release formulation of fluvastatin

Dec. 16, 1999

NIH-sponsored study fails to confirm efficacy of secretin in autism

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...